Wilbanks Smith & Thomas Asset Management’s West Pharmaceutical WST Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.06M	Hold	2,671	–	–	0.03%	223
2023 Q4	$941K	Hold	2,671	–	–	0.03%	234
2023 Q3	$1M	Hold	2,671	–	–	0.03%	225
2023 Q2	$1.02M	Hold	2,671	–	–	0.03%	221
2023 Q1	$925K	Hold	2,671	–	–	0.03%	226
2022 Q4	$629K	Hold	2,671	–	–	0.02%	271
2022 Q3	$657K	Sell	2,671 -20	-0.7%	-$6.09K	0.03%	255
2022 Q2	$814K	Buy	2,691 +5	+0.2%	+$1.63K	0.03%	242
2022 Q1	$823K	Hold	2,686	–	–	0.03%	241
2021 Q4	$1.26M	Hold	2,686	–	–	0.04%	212
2021 Q3	$1.14M	Hold	2,686	–	–	0.04%	211
2021 Q2	$965K	Hold	2,686	–	–	0.04%	230
2021 Q1	$757K	Buy	+2,686	New	+$769K	0.03%	235
2018 Q4	–	Sell	-60	Closed	-$7K	–	1315
2018 Q3	$7K	Buy	+60	New	+$6.73K	﹤0.01%	1147

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's WST Position: Q1 2024 in Review

Wilbanks Smith & Thomas Asset Management held its West Pharmaceutical (WST) position steady in Q1 2024 at 2,671 shares worth $1.06M. The position accounts for 0.03% of the portfolio, ranked #223.

Wilbanks Smith & Thomas Asset Management first reported a position in WST in Q3 2018 and has held it in 14 quarters since. The position peaked at $1.26M in Q4 2021. 779 funds tracked by Wall St. Rank hold WST as of Q1 2024.

Wilbanks Smith & Thomas Asset Management held 2,671 shares of West Pharmaceutical worth $1.06M as of Q1 2024.
Wilbanks Smith & Thomas Asset Management left its West Pharmaceutical share count unchanged in Q1 2024.
West Pharmaceutical made up 0.03% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #223 holding.
Wilbanks Smith & Thomas Asset Management first reported a position in West Pharmaceutical in Q3 2018 and has held it in 14 quarters since.
Wilbanks Smith & Thomas Asset Management's West Pharmaceutical position peaked at $1.26M in Q4 2021.
779 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.